Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Novo Nordisk's diabetes pill Rybelsus to be covered by Express Scripts
Reuters
Fri, 01/17/20 - 11:51 pm
Tags:
Novo Nordisk, Rybelsus, Express Scripts, PBMs
Novo Nordisk's blockbuster Ozempic wins FDA label boost with CV indication
Endpoints
Fri, 01/17/20 - 11:15 am
Tags:
Novo Nordisk, Ozempic, diabetes, cardiovascular events, FDA
FDA OKs Novo's Fiasp for diabetic children
Seeking Alpha
Mon, 01/6/20 - 10:36 am
Tags:
insulin, FDA, Novo Nordisk, Fiasp, pediatrics, diabetes, type 1 diabetes
Novo Nordisk Launches $99 Insulin Program
BioSpace
Thu, 01/2/20 - 11:41 pm
Tags:
Novo Nordisk, diabetes, insulin, drug pricing
Novo Nordisk joins with UVA in diabetes digital simulation project
Pharmaforum
Fri, 12/20/19 - 12:08 pm
Tags:
Novo Nordisk, UVA, R&D, type 2 diabetes
ICER Warns of ‘Short-Term Budget Challenges’ with Novo’s Rybelsus
Xtalks
Tue, 12/10/19 - 10:35 am
Tags:
Novo Nordisk, Rybelsus, oral semaglutide, diabetes, ICER, drug pricing
Novo Nordisk CEO Jørgensen aims to leverage diabetes know-how, deals into the new decade
Fierce Pharma
Wed, 11/20/19 - 10:45 pm
Tags:
Novo Nordisk, Lars Fruergaard Jorgensen, Pharma CEOs, diabetes
AZ, Merck and Novartis top Big Pharma's Q3 growth charts. Teva and Pfizer? Not so much
Fierce Pharma
Tue, 11/19/19 - 11:38 pm
Tags:
earnings, Big Pharma, AstraZeneca, Merck, Celgene, Novartis, Novo Nordisk, Pfizer
Novo Ventures Sows $25M Into Accelerator to Break Into Illustrious Mass Bio Space
Xconomy
Tue, 11/19/19 - 10:45 am
Tags:
Novo Ventures, Broad Institute, Harvard, biotech, accelerators, Massachusetts, Novo Nordisk
Dicerna scores broad, 'rest of liver' deal with Novo Nordisk, bagging $225M in cash to hit some 30 targets with RNAi platform
Endpoints
Mon, 11/18/19 - 11:33 pm
Tags:
Dicerna, Novo Nordisk, liver disease, RNAi
Novo Nordisk buys rights to NASH drug from Japan’s UBE
Pharmaforum
Fri, 11/8/19 - 10:49 am
Tags:
Novo Nordisk, NASH, Japan, UBE, UD-014
Novo Nordisk (NVO) Q3 Earnings Beat Estimates, Revenues Miss
Yahoo/Zacks.com
Mon, 11/4/19 - 10:15 am
Tags:
Novo Nordisk, earnings
Novo drops oral GLP-1 analog to focus on next-gen Rybelsus
Fierce Biotech
Fri, 11/1/19 - 10:36 am
Tags:
Novo Nordisk, diabetes, OG2023SC, Rybelsus, oral semaglutide
Why Novo Nordisk should buy Uniqure
EP Vantage
Fri, 10/11/19 - 10:31 am
Tags:
Novo Nordisk, gene editing, hemophilia, uniQure, Bluebird Bio
Novo taps bluebird bio for gene-editing tech
Fierce Biotech
Wed, 10/9/19 - 09:43 am
Tags:
Novo Nordisk, Bluebird Bio, R&D, gene editing, hemophilia
Novo Nordisk announces obesity digital health tie-up with Noom
Pharmaforum
Thu, 10/3/19 - 10:53 am
Tags:
Novo Nordisk, Noom, digital health, obesity
Mom approved: J&J, Takeda and more lead Working Mother's best places to work list for 2019
Fierce Pharma
Wed, 10/2/19 - 10:53 am
Tags:
JNJ, Takeda, parents, Eli Lilly, Merck, Novo Nordisk, Sanofi
How Big Can This $8 Billion-Plus Diabetes Drug Class Get?
Motley Fool
Fri, 09/27/19 - 09:10 am
Tags:
diabetes, Eli Lilly, Merck, Novo Nordisk, GSK, Byetta, Victoza, Bydureon, Ozempic, Tanzeum, Trulicity, Rybelsus
Novo’s new oral GLP-1 Rybelsus still has obstacles to overcome
Pharmaforum
Tue, 09/24/19 - 09:53 am
Tags:
Novo Nordisk, oral semaglutide, Rybelsus, FDA
Novo Nordisk wins FDA green light for 'holy grail' diabetes drug Rybelsus
Fierce Pharma
Fri, 09/20/19 - 01:13 pm
Tags:
Novo Nordisk, oral semaglutide, FDA, Rybelsus, type 2 diabetes

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.